Virtu Financial LLC Precision Biosciences Inc Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.34 - $0.69 $9,296 - $18,865
27,342 New
27,342 $9,000
Q3 2022

Nov 07, 2022
BUY
$1.22 - $40.8 $32,423 - $1.08 Million
26,577 New
26,577 $35,000
Q1 2021

May 19, 2021
SELL
$8.57 - $15.79 $165,975 - $305,804
-19,367 Closed
0 $0
Q4 2020

Feb 24, 2021
BUY
$5.98 - $12.47 $115,814 - $241,506
19,367 New
19,367 $162,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $584M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email